Intimation about approval of the unaudited financial results – both Stand-alone and Consolidated – for the quarter / half-year ended September 30, 2016.
REACH US
Address: D37/1, MIDC-Turbhe, Navi Mumbai
Email: investor_relations@thyrocare.com
Tel: +9122 4125 2525 / 3090 0000
CIN – L85110MH2000PLC123882
ISIN – INE594H01019